ST
Student_of_Aesop
Community Contributor
Member since 2022
Views423Total number of views
Followers24Total number of followers
Comments0Total number of comments
Is a bird in the hand worth two in the bush?
No link added
Little Green Pharma set to double revenue amidst European expansion
Forecasts for Growth, Future Revenue, Net Profit, and Key Metrics Forecasting LGP’s future performance involves assumptions based on FY2024 trends, market conditions, and strategic plans. Below are speculative projections for key metrics: Revenue Growth: FY2024 Baseline: $25.6 million, up 29% from $19.9 million in FY2023.Read more
423
users have viewed this narrative2users have liked this narrative
1users have commented on this narrative
25users have followed this narrative
ST
AU$0.42
70.2% undervalued intrinsic discount
Student_of_Aesop's Fair Value
Revenue
20.27% p.a.
Profit Margin
14.95%
Future PE
22.04x
Price in 2030
AU$0.79